In our study, we observed a significant decrease in HLA-DRA and CD4 levels in recurrent GBM and found that L + M cells in the GBM.PD1 group had substantially increased T cell-related interactions compared to the GBM.rec group. The gene discussed is CD4; the disease is glioblastoma.